The American S0ciety of Clinical Oncology conference 2023 is being held from 2nd - 6th of June
This will be an extremely important conference for all of us.
We may even have some new licensing deals relating to DD DC and DI signed at this congress
It is a forgone conclusion Starpharma will be presenting Dep Docetaxel/Cabazitaxel/Irinotecan Phase 2 clinical data results at this event
No doubt Jackie would have received Abstract notification (31st March)
We should see what the focus will be on, as of April 26 Wednesday 5pm Chicago USA (ET) Thursday 26th 5am WST (Perth)
Bearing this in mind, I would suggest our quarterly will be released to the ASX on Thursday 27th April at the latest (remembering markets will be closed in US when it is released.
Abstract Submitter Opens: November 15, 2022
Abstract Submission Deadline: February 14, 2023, at 11:59 PM (ET)
Late-Breaking Abstract Submission Deadline: March 16, 2023, at 12:00 PM (Noon) (ET)
Abstract Notification Sent to First Author: March 31, 2023
Abstract Withdrawal Deadline: April 9, 2023, at 11:59 PM (ET)
Abstract Titles, including LBAs, Released online: April 26, 2023
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)